A Agilent Technologies, Inc.
Agilent Technologies, Inc. (A) trend channel, buy level and 3-month target on Trade The Path. Sector: Healthcare. Listed on NASDAQ. Levels below are fitted to this ticker's own swing highs and lows (Theil–Sen, log-price), then projected 3 months. If this ticker has no settled sample yet, treat the numbers as a geometric read, not a track record. Information only, not financial advice.
Broken out above, going sideways on both timeframes
Price has closed above the channel. The fitted trend may no longer describe this stock.
The next few months are read from the last 12 months, not the last 3 years: that channel fits this stock's recent turns at least as well (54% against 44%) and it is the one price is respecting now. The last 3 years stay as context: going sideways, +1% a year. The nearest ceiling overhead is US$169.02, from the last 3 years. What would overturn this: a close below US$91.93 — the floor of the channel being read — after which the trend, not the entry, is what was wrong.
- 3 years
- US$105.22 – US$169.02 Sideways channel, +1% a year
- 12 months read from
- US$91.93 – US$131.49 Sideways channel, −1% a year
- Position in that channel
- 156% above the ceiling of it — 0% is the floor, 100% the ceiling
Price history, with the path projected 3 months forward
- Daily close
- Upper trend line (3 years)
- Lower trend line (3 years)
- The same lines over the last 12 months
- Dashed after today: projected 3 months
- Our buy
- Our target
Our target
No published call today because no target size has paid on this stock’s own record, so there is none to publish. No alerts are sent. The buy and target below are still this site's read of the fitted channel.
Buy at or below
US$105.21
level as at 17 Sept 2026
Our target
US$172.09
by 16 Dec 2026
Projected move
63.6%
gross, before costs
Price sits between our buy level and our target.
- Upper line touches
- 6
- Lower line touches
- 10
- Fit confidence
- 44%
- Fitted
- 16 Sept 2026
About Agilent Technologies, Inc.
Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Padraig McDonnell
- Employees
- 18,100
- Country
- US
Scorecard
Our own pillar scores, computed from the fundamentals below. They are not Morningstar ratings — that data is licensed and we do not redistribute it.
- Valuation
- —
- Profitability
- —
- Financial health
- —
- Cash generation
- —
Key statistics
- Market cap
- US$43.41B
- Enterprise value
- —
- Beta
- 1.24
- Avg volume
- 2.29M
- Revenue per share
- —
- Dividend yield
- —
- 52-week range
- 108.35-163.75
- Exchange
- NYSE
Key ratios
- P/E (TTM)
- —
- PEG
- —
- Price / sales
- —
- Price / book
- —
- EV / EBITDA
- —
- Gross margin
- —
- Operating margin
- —
- Net margin
- —
- Current ratio
- —
- Quick ratio
- —
- Debt / equity
- —
- Interest cover
- —
Income statement
Balance sheet
Cash flow
Trend lines are fitted statistically to past swing highs and lows and projected forward on the assumption the same rhythm continues. It often does not. This is information, not advice.